Martinez-Molina, C, Vidal, S, Diaz-Torne, C, Park, HS, Corominas, H. Interindividual variability and its impact on the effectiveness of Janus kinase inhibitors in rheumatoid arthritis treatment. Frontiers in Medicine. 2025; 12DOI:10.3389/fmed.2025.1512501. PMID:40224626. IF:3.000(Q1/2D).

Borque-Fernando, A, Alonso-Gordoa, T, Juan-Fita, MJ, Campos, FL, Pérez-Fentes, DA, Vilaseca, A, Agut, CM, Usán, P, Rey, PM. Beyond the status quo: when disease volume and metastatic timing are not enough to personalize treatment in mHSPC. Future Oncology. 2025; 21(8)DOI:10.1080/14796694.2025.2468569. PMID:40029138. IF:2.600(Q3/6D).

Ivain, P, Baksh, A, Saini, F, Idris, M, Tamayo-Elizalde, M, Wells, J, Benejam, B, Loosli, SV, Sandkühle, K, Wlasich, E, Wagemann, O, Levin, J, Martet, D, Sacco, S, Falquero, S, Clert, M, Rebillat, AS, Khoo, WM, Smith, MA, Beresford-Webb, J, Zaman, S, Carmona-Iragui, M, Videla, L, Fortea, J, Langballe, EM, Medboen, IT, Larsen, FK, Baldimtsi, E, Paradisi, R, Ntailakis, P, Tsolaki, M, Papantoniou, G, Mcglinchey, E, Mccarron, M, Kennelly, S, Strydom, A. Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium study. ALZHEIMERS & DEMENTIA. 2025; 21(3)DOI:10.1002/alz.70071. PMID:40145416. IF:11.100(Q1/1D).

Tibau, A, Hwang, TJ, Romano, A, Borrell, M, Gich, I, Molto, C, Kesselheim, AS. Factors in Time to Full Approval or Withdrawal for Anticancer Medicines Granted Accelerated Approval by the FDA. JAMA Network Open. 2025; 8(3)DOI:10.1001/jamanetworkopen.2025.2026. PMID:40136298. IF:9.700(Q1/1D).

Matthews, I, Mehra, P, Suárez-Calvet, X, Piñol-Jurado, P, Cox, D, Justian, V, Carrasco-Rozas, A, Laidler, Z, Bowey, A, Rushton, P, López-Fernández, S, Díaz-Manera, J, Fernández-Simón, E. Strategy for drug repurposing in fibroadipogenic replacement during muscle wasting: application to duchenne muscular dystrophy. Frontiers in Cell and Developmental Biology. 2025; 13DOI:10.3389/fcell.2025.1505697. PMID:40206397. IF:4.300(Q1/1D).

Lopez-Rey, BG, Carot-Sans, G, Ouchi, D, Torres, F, Pontes, C. Use of Bayesian approaches in oncology clinical trials: A cross-sectional analysis. Frontiers in Pharmacology. 2025; 16DOI:10.3389/fphar.2025.1548997. PMID:40201693. IF:4.800(Q1/2D).

Mondesert, E, Delaby, C, de la Cruz, E, Kuhle, J, Benkert, P, Pradeilles, N, Duchiron, M, Morchikh, M, Camu, W, Cristol, JP, Hirtz, C, Esselin, F, Lehmann, S. Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis. NEUROLOGY. 2025; 104(6)DOI:10.1212/WNL.0000000000213400. PMID:40009787. IF:8.500(Q1/1D).

Criado, JLI, Ortiz, M, García-Fernández, J, Martínez-Alday, JD, Font, ER, Moreno, J, López, MA, Almor, JM, Gil, ML, Medina, DG, Granell, RR, Peinado, RP, Gelizo, VB, Muñoz, JJS, Medina, O, Díaz-Parreño, SA, Criado, AI, Gonzalez, JM, Merodio, JMO, Almendral, J. Can ICD Electrograms Help Ventricular Tachycardia Ablation? Results From the Multicenter Randomized AIDEG-VTA Trial. JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2025; 85(11)DOI:10.1016/j.jacc.2024.10.104. PMID:39772368. IF:22.300(Q1/1D).